The EHC welcomed the opportunity to contribute to the European Commission’s public consultation on the draft implementing regulation on Joint Scientific Consultations (JSC) for Medicinal Products, for which we issued nine recommendations.

This EU initiative sets out implementing rules detailing how developers can receive early guidance on the evidence and data needed to carry out a joint clinical assessment of their medicinal products.